Table 1.
Assays | Free | Esterified | Insoluble-Bound | |||
---|---|---|---|---|---|---|
Untreated | HPP-Treated | Untreated | HPP-Treated | Untreated | HPP-Treated | |
ARSA (mg TE/100 g) | 589.18 ± 2.18 a | 565.43 ± 2.06 b | 89.67 ± 0.94 a | 76.54 ± 0.75 b | 109.03 ± 0.98 a | 94.76 ± 0.58 b |
DRSA (mg TE/100 g) | 330.56 ± 1.68 b | 346.48 ± 1.06 a | 39.76 ± 0.52 b | 43.72 ± 0.75 a | 66.78 ± 0.76 b | 72.76 ± 0.58 a |
HRSA (mg TE/100 g) | 598.33 ± 1.58 | 598.93 ± 1.05 | 131.89 ± 0.82 | 132.37 ± 0.75 | 226.76 ± 1.5 b | 254.3 ± 0.58 a |
MCA (mg EDTAE/100 g) | 18.68 ± 0.28 b | 25.67 ± 1.05 a | 4.09 ± 0.2 b | 11.78 ± 0.75 a | 6.45 ± 0.42 | 7.27 ± 0.58 |
Different lowercase letters for the same phenolic fraction indicate significant differences (p < 0.05) among treatments. ARSA, ABTS radical scavenging activity; DRSA, DPPH radical scavenging activity; HRSA, hydroxyl radical scavenging activity; MCA, metal chelation activity; TE, Trolox equivalents; EDTAE, ethylenediaminetetraacetic acid equivalents.